跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADTRALZA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ADTRALZA
Authorized
STANDARD
ADTRALZA
LEO Pharma Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
41adda56a5c88320
Company
LEO Pharma Inc
Type
Standard
Approval Details
Approval Id
41adda56a5c88320
Drug Approval Canada Name
ADTRALZA
Product Name
ADTRALZA
Status
Marketed
Status Date
2022-03-17
Original Market Date
2022-03-17
Din
02521288
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
84:06.28
Atc Original
D11AH07 TRALOKINUMAB
Atc Name
d 11 ah 07
Aig Number
0163195001
Company Name
LEO Pharma Inc
Company Address
6 Adelaide Street East, Suite 200, Toronto, Ontario, Canada, M5C 1H6
Company Detail Path
/organization/leo-pharma-inc
Company Information
Pharmaceutical Company Name
LEO Pharma Inc
Country Name
Canada
Province Name
Ontario
City Name
thornhill,ontario,country_ca
Address
400-123 Commerce Valley Dr E
Active Ingredients
TRALOKINUMAB
150 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
41adda56a5c88320
Type
Standard
Back to Health Canada Approvals